| Test |
In Range |
Out Of Range |
Units |
Reference |
| Vitamin B12 |
483 |
|
pg/mL |
211 - 911 |
| Creatine Kinace CPK |
148 |
|
U/L |
20 - 260 |
| Acetylcholine Binding Antibody |
< 0.30 |
|
nmol/L |
<= 0.30 |
Immunofixation, Serum
|
Immunofixation studies revealed ONE trace concentration band(s) migrating in the GAMMA region which was/were of too low a concentration to definitively identify. |
| |
| Borrelia burgdorferi Total Antibody |
< 0.90 |
|
|
< 0.90 |
| |
As recommended by the Food and Drug Administration (FDA), all samples with positive or equivocal results in a Borrelia burgdorferi antibody screen will be tested using a blot method. Positive or equivocal screening test results should not be interpreted as truly positive until verified as such using a supplemental assay (e.g., B. burgdorferi blot). The screening test and/or blot for B. burgdorferi antibodies may be falsely negative in early stages of Lyme disease, including the period when erythema migrans is apparent. | |
| |
| Mercury, Whole Blood |
< 2 |
|
ug/L |
< 11 |
| |
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical. |
| |
| Methylmalonic Acid |
216 |
|
nmol/L |
87 - 318 |
| RPR |
Non reactive |
|
|
Non Reactive |
| Calcium, Ionized |
1.18 |
|
mmol/L |
1.13 - 1.32 |
| Parathyroid Test (PTH) |
38 |
|
pg/mL |
14 - 72 |